GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

9 Months Ended

Jul. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill balances and movements for each reportable segments during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the nine months ended July 31, 2017:



	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total
	(in millions)
Goodwill as of October 31, 2016	$	790	$	1,223	$	504	$	2,517
Foreign currency translation impact	5		11		3		19
Goodwill arising from acquisitions	25		51		—		76
Goodwill as of July 31, 2017	$	820	$	1,285	$	507	$	2,612

Components of other intangibles during the period

The components of other intangibles as of July 31, 2017 and October 31, 2016 are shown in the table below:



	Purchased Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in millions)
As of October 31, 2016
Purchased technology	$	823	$	572	$	251
Backlog	1		1		—
Trademark/Tradename	149		61		88
Customer relationships	263		211		52
Total amortizable intangible assets	1,236		845		391
In-Process R&D	17		—		17
Total	$	1,253	$	845	$	408
As of July 31, 2017
Purchased technology	$	856	$	630	$	226
Trademark/Tradename	149		70		79
Customer relationships	155		106		49
Total amortizable intangible assets	1,160		806		354
In-Process R&D	21		—		21
Total	$	1,181	$	806	$	375

Schedule of estimated future amortization expense of finite-lived intangible assets

Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2017 and for each of the five succeeding fiscal years and thereafter is estimated below:



Estimated future amortization expense:
(in millions)
Remainder of 2017	$	27
2018	$	91
2019	$	66
2020	$	55
2021	$	43
2022	$	31
Thereafter	$	41